Individualized Quality Control Plan (IQCP): Is It Value-Added for Clinical Microbiology?

Area of Science:

• Clinical laboratory science
• Medical diagnostics
• Regulatory compliance

Background:

• The Center for Medicaid and Medicare Services (CMS) introduced the Individualized Quality Control Plan (IQCP).
• This plan becomes the sole quality control (QC) option from January 2016 for laboratories not using Clinical Laboratory Improvement Act (CLIA) default QC.
• Previous methods like "equivalent QC" (EQC) and Clinical and Laboratory Standards Institute (CLSI) standards are no longer sufficient for microbiology system QC.

Purpose of the Study:

• To inform clinical microbiology laboratories about the upcoming changes in quality control regulations.
• To highlight the mandatory shift towards the Individualized Quality Control Plan (IQCP).
• To note the discontinuation of "equivalent QC" (EQC) and reliance on CLSI standards alone.

Main Methods:

• Analysis of the new CMS Individualized Quality Control Plan (IQCP) regulations.
• Comparison of IQCP requirements with previous quality control (QC) methodologies.
• Assessment of the impact on clinical microbiology laboratory operations.

Main Results:

• The Individualized Quality Control Plan (IQCP) will be the mandatory QC standard from January 2016 for many laboratories.
• Laboratories must cease using "equivalent QC" (EQC) or solely CLSI standards for microbiology QC.
• The implementation is anticipated to be an added burden for clinical microbiology laboratories.

Conclusions:

• Clinical microbiology laboratories must adapt to the new Individualized Quality Control Plan (IQCP) by January 2016.
• The benefits and practical implications of IQCP implementation remain to be determined.
• Laboratories face a significant regulatory shift impacting their quality control processes.